1INSERM U 169, Villejuif, France.
This study introduces a new group sequential analysis method for clinical trials. It ensures overall significance level alpha and avoids inconsistencies found in prior sequential testing approaches.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: